NSCLC (Non-small Cell Lung Carcinoma) Terminated Phase 2 Trials for Itacitinib (DB12154)

IndicationStatusPhase
DBCOND0103105 (NSCLC (Non-small Cell Lung Carcinoma))Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02257619Study of INCB039110 in Combination With Docetaxel in Subjects With Non-Small Cell Lung CancerTreatment